Continuous Glucose Monitoring (CGM) Systems/Devices Market (By Component: Transmitters & Receivers, Sensors, Insulin Pumps; By End-use: Hospitals, Homecare Settings, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Published at : February-2019 | Delivery Format : PDF | Status: Published | Pages : 160


The global Continuous Glucose Monitoring (CGM) Systems/Devices market size is anticipated to around USD 2.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period.

Market Dynamics

Developing instances of diabetes, combined with expanding adoption of continuous glucose monitoring (CGM) gadgets, has been driving the market. CGM frameworks are insignificantly obtrusive and offer a simple and compelling approach to manage diabetes. They can likewise recognize radical changes in blood glucose level, in this way avoiding hypoglycaemic conditions.

These gadgets encourage examination of blood glucose levels at various time interims with the assistance of a sensor. Individual readings nourished into to a diabetes the board programming through a remote system enable patients to comprehend the disease better, subsequently helping them to oversee it in a progressively powerful manner.

Market Insights

The market is assessed to enlist a CAGR of 13.7% over the forecast period. Developing instances of diabetes and presentation of novel and propelled diabetes care gadgets are the central point driving the market development. Consistent glucose checking gadgets or glucose monitoring devices give an effective technique to gauge body glucose levels progressively in real time. Information recorded by these gadgets is transmitted through a remote system to recipients; this helps monitor glucose levels over an assigned period.

These gadgets likewise help manage diabetes while decreasing individual insulin measurements. Incorporated programming inside these gadgets furnishes clients with bits of knowledge about food consumption, physical activity, medication, and illnesses. Consequently, an expanding number of diabetic patients are utilizing these gadgets to oversee and treat diabetes, which, thusly, is quickening market development. With the coming of computerized therapeutics, a rising number of CGM gadgets are being joined with applications and programming to assist patients with diabetes mellitus. Ascend in the quantity of diabetes mellitus has been contributing toward market development.

Market Segmentation

Market By Component

  • Transmitters & Receivers
  • Sensors
  • Insulin Pumps

Market By End-use

  • Hospitals
  • Homecare Settings
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

The North American district is relied upon to lead the worldwide market. Expanding instances of diabetes and endeavours taken by the national government to deal with the disease at a bigger dimension are required to drive the area's development. Rising adoption of exchange and novel gadgets have been seen in the area, accelerating market development. Preventive measures taken by the government to enable diabetic people to comprehend and deal with the illness before genuine results happen are the key driver for the regional market. The locale is relied upon to prosper attributable to technological advancements and considerable research and development in diabetes care.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the Continuous Glucose Monitoring (CGM) Systems/Devices are GlySens, Pfizer Inc., Ypsomed, Baxter International Inc., Novo Nordisk, Abbott Laboratories, Animas Corporation, and Medtronic, Inc. Organizations are additionally progressively growing new products, which has additionally supported in the development of their current portfolio with progressive technologies. For example, in February, 2016 Animas Corporation declared the dispatch of Animas Academy in the Ireland and U.K., which is an instructive program for people managing diabetes with an insulin pump and strengthening innovation related with it.

Cart Summary